DCTI mission

DCTI is a research initiative to improve beta-cell replacement therapy and to make this therapy accessible for more patients with diabetes. The main research goals are to increase the availability of high quality insulin-producing cells and the development of alternative transplantation sites and to identify factors for long-term islet function and survival with the use of biomaterials.

Five research areas contribute to this goal:

_{Schematic overview of overarching goal with time line and research areas}

New Partners

Several DCTI partners have joined RegMed XB (www.regmedxb.com) to build on the knowledge generated within DCTI.

Contact

Eelco de Koning (Scientific Director)
e.dekoning[at]lumc[dot]nl
071-5262085

Margot Beukers (Managing Director)
dcti[at]sbsupport[dot]nl
071-5324733